NOVARTIS INDIA
Back to Cashflow Statement
|
NOVARTIS INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-64 Cr | ₹-121 Cr | ₹-30 Cr | ₹-36 Cr | ₹-37 Cr |
What is the latest Cash Flow from Financing Activities ratio of NOVARTIS INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-64 Cr |
| Mar2024 | ₹-121 Cr |
| Mar2023 | ₹-30 Cr |
| Mar2022 | ₹-36 Cr |
| Mar2021 | ₹-37 Cr |
How is Cash Flow from Financing Activities of NOVARTIS INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-64 Cr | Negative | |
| Mar2024 | ₹-121 Cr | Negative | |
| Mar2023 | ₹-30 Cr | Negative | |
| Mar2022 | ₹-36 Cr | Negative | |
| Mar2021 | ₹-37 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NOVARTIS INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NOVARTIS INDIA | ₹2,273.8 Cr | -1.5% | 20.4% | 11.2% | Stock Analytics | |
| ADANI ENTERPRISES | ₹268,309.0 Cr | -7% | 4.1% | 2.8% | Stock Analytics | |
| REDINGTON | ₹19,509.2 Cr | 2.8% | -7.1% | 5.4% | Stock Analytics | |
| HONASA CONSUMER | ₹9,432.5 Cr | -4.7% | 5.3% | 32.1% | Stock Analytics | |
| MMTC | ₹8,406.0 Cr | -10.2% | -10.7% | 9.2% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹7,057.3 Cr | -14.6% | -19.6% | 16.1% | Stock Analytics | |
NOVARTIS INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NOVARTIS INDIA | -1.5% |
20.4% |
11.2% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses